Mirum Pharmaceuticals

About:

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

Website: https://mirumpharma.com

Twitter/X: mirumpharma

Top Investors: New Enterprise Associates, Rock Springs Capital, Frazier Healthcare Partners, Novo Holdings, RiverVest

Description:

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.